| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.08 |